Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.04.15.647522

Toward Unified Biomarkers for Focal Epilepsy

Abstract

Accurately localizing the epileptogenic network (EpiNet) remains a major barrier to effective epilepsy treatment, largely due to limited mechanistic understanding. The EpiNet is a patient-specific brain network shaped by complex, overlapping pathology. While combining biomarkers can improve localization, it also generates high-dimensional feature data that increases the risk of overfitting and reduces interpretability. We hypothesized that the core epileptogenic dynamics could be captured in a low-dimensional latent space derived from empirical data, without the need to record seizures. From interictal stereo-EEG (SEEG) recordings in 64 patients (29 females), we extracted 260 neuronal features and reduced them to 10 latent components using singular value decomposition. A classifier trained on these 10 components was then simplified into a probabilistic EpiNet model requiring only two components as input. Individual position in this two-dimensional latent space correlated with previously reported classification accuracy (r2=0.5), supporting its functional relevance. In three independent patients, the probabilistic model captured time-varying epileptogenic dynamics during sleep-SEEG recordings, corroborated clinical assessments, and achieved peak classification accuracies of 0.63, 0.85, and 0.94. These predictions were independently validated by tensor component analysis. Together, these results provide evidence for a robust low-dimensional representation of epileptogenicity across brain states and pathological substrates. This approach simplifies interpretation, facilitates integration of additional biomarkers, and enables large-scale cohort analyses, establishing a proof of concept for a unified framework for epilepsy biomarkers. Significance StatementTo advance mechanistic understanding of large-scale brain dynamics underlying epilepsy, we combined novel epilepsy biomarkers with interpretable machine learning. From interictal SEEG, we extracted 260 connectivity and criticality features. Dimensionality reduction of these raw features showed that only two components were needed to identify epileptogenic networks, reducing the feature space by >99%. These components were highlighted by abnormal power-law scaling, bistability, and strong inhibition or excitation in the 15-200 Hz range, consistent with prior findings. The model tracked neuropathological dynamics over hours and was validated through tensor component analysis, suggesting that epileptogenic activity is dynamic, subject-specific, and sparsely represented in both state space and cortical networks.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Wang, S. H., Ferrari, P., Arnulfo, G., Marzulli, M., Degras, D., Myrov, V., Palva, S., Nobili, L., Ciuciu, P., Palva, M.. 2025-04-20. Toward Unified Biomarkers for Focal Epilepsy. https://doi.org/10.1101/2025.04.15.647522

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Neurodegeneration-inducing macromolecules exit the brain via nanovascular conduits formed by reticular fibroblasts

Accumulation of proteins such as amyloid beta (Abeta), hyperphosphorylated tau and alpha-synuclein within the brain alters neural information processing and causes neurodegeneration(1-3), but how toxic solutes are cleared from the brain remains highly controversial(4,5). Proposed exit routes include efflux across endothelial cells into the blood(6,7), and movement to the pial surface via vasomotion-induced pumping along spaces within arteriolar smooth muscle(8) or via outflow along the perivascular space of ascending venules promoted by water flux through astrocytes (the glymphatic system(9)). From the pial surface of the brain, drainage may continue to dural lymphatics, along the outer sheaths of exiting cranial nerves and across the cribriform plate(10-14). We now report the presence, in mice and humans, of 2 micron diameter conduits that remove fluorescently labelled tau and Abeta from the brain. These conduits form a spatially-organised mesh within the walls of penetrating arterioles and pial arteries, and around the surface of ascending venules and deep cerebral and pial veins. They course through the pial and arachnoid layers to span the CSF space, wrapping the brain and cranial nerves. They are formed of reticular fibroblasts, which label for VE-cadherin(15) and PDGFRalpha(16), the lymphatic markers(17) podoplanin, VEGFR3 and Prox1, and reticular fibroblast extracellular matrix components collagen I and VI(16,18-20). Parenchymal tau drains from the brain at a similar rate via arteriolar conduits and via conduits around venules, arguing against preferential removal by a glymphatic mechanism. In Alzheimer's disease model mice, Abeta is seen traversing these lymph node-like conduits. Modulation of molecular transfer via this route may accelerate or delay cognitive decline, and slowed transfer from arteriolar to pial-arachnoid conduits may initiate cerebral amyloid angiopathy.

neuroscience↗

Analysis of the influence of gradual changes in matrix sentence similarity on neural envelope tracking

Neural tracking of speech is a well-established phenomenon in neuroscience. However, for speech signals with a fixed structure, significant correlations between speech envelopes and neurophysiological representations occur even for unheard sentences. We exploit a structured speech-in-noise matrix hearing test (Oldenburger Sentence Test, OLSA) to systematically quantify the relationship between acoustic sentence similarity and neural tracking. Simultaneous magnetoencephalography (MEG) and 76-channel electroencephalography (EEG) data, including 16 channels positioned directly around the ears (ear-EEG), were recorded from 21 young adults with normal hearing during the presentation of clean-speech audiobooks and OLSA sentences at six signal-to-noise ratios. A linear decoder trained on audiobooks reconstructed OLSA sentence envelopes. Reconstruction accuracies were compared using a linear mixed model across heard (matched) and unheard (mismatched) sentences of varying acoustic similarity. Significant reconstruction accuracies were achieved across MEG, EEG, and ear-EEG for both matched and mismatched sentences. For mismatched sentences, these accuracies gradually increased with their acoustic similarity to the heard speech data. The high similarity between sentences, which is especially prominent in matrix tests, can cause significant spurious tracking for mismatched stimuli. This effect can reach levels comparable to those of matched sentences and can be mistaken for true neural tracking. Robust neural tracking across modalities further supported the established viability of ear-EEG compared to whole-head systems.

neuroscience↗

Seizures and tauopathy following neurotrauma are mediated by prion protein and metabotropic glutamate receptor 5

Traumatic brain injury (TBI) is one of the world's leading causes of death and disability and a major risk factor for dementias. The primary dementia associated with TBI is chronic traumatic encephalopathy (CTE), a neurodegenerative disease classified as a tauopathy, in which toxic tau molecules lead to disease pathologies and degeneration. The processes that lead to tauopathy and subsequent dementia after TBI remain unclear. Here, we built upon the finding that seizures after TBI may be a mechanism leading to tauopathy, by dissecting the functions of the metabotropic glutamate receptor 5 - cellular prion protein (mGluR5-PrPC) pathway. We delivered TBI to larval in a blast paradigm, and quantified aggregation of Tau via a genetically-encoded Tau-GFP fusion reporter. Zebrafish larvae lacking prp2 (homolog of mammalian cellular Prion Protein, PrPC) displayed a 168% increase in post-traumatic seizures activity after TBI. An mGluR5 agonist (CHPG) reduced post-traumatic seizures, whereas an mGluR5 antagonist (MPEP) increased post-traumatic seizures. Moreover, agonizing mGluR5 reduced tau aggregation and antagonizing mGluR5 increased tau burden. Larvae seizing from convulsants, rather than TBI, were treated with CHPG/MPEP and provided a similar pattern of outcomes, suggesting seizures may be a factor needed for mGluR5 activity to influence tau aggregation. The PrPC-mGluR5 pathway is proposed as one candidate pathomechanism linking TBI to subsequent seizures and tauopathy, and thus it warrants investigation as a target for prophylactic interventions.

neuroscience↗